9EK0
Human M5 muscarinic acetylcholine receptor complex with mini-Gq and iperoxo
Summary for 9EK0
| Entry DOI | 10.2210/pdb9ek0/pdb |
| EMDB information | 48111 |
| Descriptor | Muscarinic acetylcholine receptor M5, Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, Guanine nucleotide-binding protein Gq alpha subunit chimera, ... (5 entities in total) |
| Functional Keywords | g protein-coupled receptor, acetylcholine binding, seven transmembrane protein, membrane protein |
| Biological source | Homo sapiens (human) More |
| Total number of polymer chains | 4 |
| Total formula weight | 113524.91 |
| Authors | |
| Primary citation | Burger, W.A.C.,Mobbs, J.I.,Rana, B.,Wang, J.,Joshi, K.,Gentry, P.R.,Yeasmin, M.,Venugopal, H.,Bender, A.M.,Lindsley, C.W.,Miao, Y.,Christopoulos, A.,Valant, C.,Thal, D.M. Cryo-EM reveals an extrahelical allosteric binding site at the M 5 mAChR. Nat Commun, 16:7046-7046, 2025 Cited by PubMed Abstract: The M muscarinic acetylcholine receptor (M mAChR) represents a promising therapeutic target for neurological disorders. However, the high conservation of its orthosteric binding site poses significant challenges for drug development. While selective positive allosteric modulators (PAMs) offer a potential solution, a structural understanding of the M mAChR and its allosteric binding sites remains limited. Here, we present a 2.8 Å cryo-electron microscopy structure of the M mAChR complexed with heterotrimeric G protein and the agonist iperoxo, completing the active-state structural characterization of the mAChR family. To identify the binding site of M-selective PAMs, we implement an integrated approach combining mutagenesis, pharmacological assays, structural biology, and molecular dynamics simulations. Our mutagenesis studies reveal that selective M PAMs bind outside previously characterized M mAChR allosteric sites. Subsequently, we obtain a 2.1 Å structure of M mAChR co-bound with acetylcholine and the selective PAM VU6007678, revealing an allosteric pocket at the extrahelical interface between transmembrane domains 3 and 4 that is confirmed through mutagenesis and simulations. These findings demonstrate the diverse mechanisms of allosteric regulation in mAChRs and highlight the value of integrating pharmacological and structural approaches to identify allosteric binding sites. PubMed: 40745154DOI: 10.1038/s41467-025-62212-z PDB entries with the same primary citation |
| Experimental method | ELECTRON MICROSCOPY (2.79 Å) |
Structure validation
Download full validation report






